# Filing Detail

Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-20-011311
Filing Date
2020-05-19
Accepted
2020-05-19 17:29:39
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 424B5 | dffn20200518_424b5.htm | 424B5 | 544230
2 |  | dffn20190514_s3img003.gif | GRAPHIC | 40946
3 |  | dffn20190514_s3img004.gif | GRAPHIC | 41077
4 |  | dffn20200518_424b5img001.jpg | GRAPHIC | 9279
5 |  | logo1.jpg | GRAPHIC | 570608
6 |  | s3img002.jpg | GRAPHIC | 43900
| Complete submission text file | 0001437749-20-011311.txt |  | 1513820

Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-231541 | Film No.: 20894842
SIC: 2834 Pharmaceutical Preparations